LanZhou Foci Pharmaceutical Co.,Ltd.

002644

CNE1000019W4

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 22/05/2024 am IST			5-day change	1st Jan Change
7.64 ^CNY	+0.39%		-2.43%	-21.64%

10/04	Lanzhou Foci Pharmaceutical Chairman Resigns	MT
10/04	Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2023	CI

LanZhou Foci Pharmaceutical Co.,Ltd. Announces Executive Changes

January 03, 2020 at 08:02 pm IST

LanZhou Foci Pharmaceutical Co.,Ltd. elected Shi Aiguo; Shang Shoupeng; Wang Yingchun; and Du Xiaozheng as non-independent directors Liu Zhijun; Long Fengming; and Zhao Xinmin as independent directors Su Wenbo as a supervisor, at its Extraordinary General Meeting of 2020 held on 02 January 2020.

Latest news about LanZhou Foci Pharmaceutical Co.,Ltd.

Lanzhou Foci Pharmaceutical Chairman Resigns	10/04	MT
Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for the Year 2023	10/04	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/04	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	09/04	CI
Lanzhou Foci Pharma to Buy 60% Stake in Local Peer for 15.5 Million Yuan	26/12	MT
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/23/30	CI
Gansu Provincial State-owned Asset Investment Group Co.,Ltd completed the acquisition of 0.80% stake in LanZhou Foci Pharmaceutical Co.,Ltd. for CNY 39 million.	23/23/23	CI
LanZhou Foci Pharmaceutical Co.,Ltd.(XSEC:002644) added to S&P Global BMI Index	18/23/18	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	02/23/02	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on June 15, 2023	08/23/08	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/23/25	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2022	22/23/22	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Announces Final Cash Dividend (Tax Included) for 2022	01/23/01	CI
Gansu Provincial State-owned Asset Investment Group Co.,Ltd made a tender off to acquire a 38.37% stake in LanZhou Foci Pharmaceutical Co.,Ltd. for CNY 1.8 billion.	28/23/28	CI
Lanzhou Foci Pharma Appoints CFO	02/22/02	MT
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/22/26	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/22/24	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on May 27, 2022	21/22/21	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend for 2021	17/22/17	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	15/22/15	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/21/26	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	19/21/19	CI
LanZhou Foci Pharmaceutical Co.,Ltd. Proposes Final Cash Dividend on A Shares for the Year 2020, Payable on July 9, 2021	03/21/03	CI
Lanzhou Foci Pharmaceutical Co.,Ltd. Approves Final Dividend for the Year 2020	13/21/13	CI

Chart LanZhou Foci Pharmaceutical Co.,Ltd.

Duration

Period

Chart LanZhou Foci Pharmaceutical Co.,Ltd.

More charts

Company Profile

LanZhou Foci Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs and large health products. The Companyâs main products are categorized into pills, tablets, granules, syrups, capsules, glue and others, including Liuwei Dihuang pills, Xiaoyao Pill, Xiangsha Yangwei pills, ginseng Gubeng Huanhao pills and other Chinese patent drugs, as well as large health products, such as Ejiao and Ejiao loafs. The Company distributes its products under the brand names Foci, Baolu and Mianshan. The Company is also involved in the cultivation, processing and marketing of Chinese herbal medicine. The Company distributes its products in domestic market and to overseas markets.

Sector

Pharmaceuticals

Calendar

26/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
LANZHOU FOCI PHARMACEUTICAL CO.,LTD.	-21.64%	54Cr
DONG-E-E-JIAO CO.,LTD.	+38.28%	606.58Cr
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-16.91%	442.34Cr
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+5.14%	326.2Cr
TASLY PHARMACEUTICAL GROUP CO., LTD	-14.63%	299.8Cr
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-4.12%	246.77Cr
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+42.14%	189.42Cr
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-10.63%	163.06Cr
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-2.71%	160.21Cr
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-12.26%	154.35Cr